Ceres Nanosciences, Manassas, Va, has completed the build-out of a new 12,000-square-foot Advanced Particle Manufacturing Plant in Innovation Park, Prince William County, Virginia. The new facility will be capable of generating a supply of Ceres’ Nanotrap Magnetic Virus Particles to enable more than 10 million covid-19 tests per month, with room for added capacity in the future.
Nanotrap Magnetic Virus Particles improve diagnostic testing for covid-19 by eliminating the need for RNA extraction kits, reducing sample processing time, and improving the sensitivity of the downstream assays in point-of-care systems, high-throughput laboratory tests, and wastewater and pooled sample testing workflows. Nanotrap Magnetic Virus Particles also improve diagnostic testing for influenza virus, RSV, and variants of SARS-CoV-2.
The new facility was constructed in under 4 months with funding support from the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx) initiative.
“This new facility is a huge step up in capacity for Ceres, giving us the ability to rapidly respond and scale to current and future virus outbreaks and testing needs,” says Ross Dunlap, Ceres Nanosciences CEO.
“We are thrilled that our new manufacturing plant is also located within Innovation Park near our existing R&D facility,” says Ben Lepene, Ceres Nanosciences CTO. “This means that we can ensure a stable supply of Nanotrap particles to our growing portfolio of customers while simultaneously maintaining our development efforts for new Nanotrap products right down the street.”
For more information, visit Ceres Nanosciences.